The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.

The metastatic process is the most serious cause of cancer death. Norepinephrine, secreted in chronic stress conditions, stimulates the motility of breast and colon cells through β-adrenergic receptor. On these bases, we examined its possible role in metastasis formation and development in vitro and in vivo. Treatments with norepinephrine (β2-adrenoreceptor agonist) in mice xenografted with human DU145 prostate cancer cells increased the metastatic potential of these cells. Specifically, we showed that treatment of mice with norepinephrine induced a significant increase of the migratory activity of cancer cells in a concentration-dependent manner and that this process was blocked by propanolol (β-adrenergic antagonist). Mice treated with norepinephrine, displayed an increased number of metastatic foci of DU145 cells in inguinal lymph nodes and also showed an increased expression of MMP2 and MMP9 in tumor samples compared to controls. Moreover, we demonstrated that propanolol induced in norepinephrine treated DU145 cells a E-cadherin finger-like membrane protrusions driven by vimentin remodeling. Altogether these data suggest that β2-AR plays an important role in prostate cancer metastasis formation and that the treatment with antagonist propanolol, could represents an interesting tool to control this process in cells overexpressing β2AR.

[1]  Xi Chen,et al.  Novel regulatory program for norepinephrine-induced epithelial–mesenchymal transition in gastric adenocarcinoma cell lines , 2014, Cancer science.

[2]  T. Eubank,et al.  The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer. , 2013, Cancer biomarkers : section A of Disease markers.

[3]  Peter Kuhn,et al.  Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. , 2013, Cancer research.

[4]  Steve W. Cole,et al.  Neuroendocrine influences on cancer progression , 2013, Brain, Behavior, and Immunity.

[5]  Sandeep Robert Datta,et al.  Behavioral stress accelerates prostate cancer development in mice. , 2013, The Journal of clinical investigation.

[6]  V. Farini,et al.  β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines , 2013, Laboratory Investigation.

[7]  A. Baum,et al.  Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts , 2013, Stress.

[8]  Bruna Maria Rodrigues Vilardi,et al.  VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors , 2013, Tumor Biology.

[9]  W. Muller.  Regulate globally, act locally: adrenergic nerves promote leukocyte recruitment. , 2012, Immunity.

[10]  A. Levine,et al.  Chronic restraint stress attenuates p53 function and promotes tumorigenesis , 2012, Proceedings of the National Academy of Sciences.

[11]  A. Abbruzzese,et al.  Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth , 2012, Journal of cellular and molecular medicine.

[12]  Steven W. Cole,et al.  Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.

[13]  Kunhong Xiao,et al.  A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 , 2011, Nature.

[14]  A. Sood,et al.  Stress Influences on Anoikis , 2011, Cancer Prevention Research.

[15]  Anil K Sood,et al.  Impact of stress on cancer metastasis. , 2010, Future oncology.

[16]  A. Sood,et al.  The sympathetic nervous system induces a metastatic switch in primary breast cancer. , 2010, Cancer research.

[17]  M. Antoni,et al.  Host factors and cancer progression: biobehavioral signaling pathways and interventions. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Q. Ma,et al.  Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction: The Study of &bgr;-Adrenoceptor Antagonist's Anticancer Effect in Pancreatic Cancer Cell , 2009, Pancreas.

[19]  H. Schuller.  Neurotransmission and cancer: implications for prevention and therapy , 2008, Anti-cancer drugs.

[20]  J. Fiedler,et al.  Stress promotes development of ovarian cysts in rats , 1998, Endocrine.

[21]  K. Lang,et al.  Neurotransmitter effects on tumor cells and leukocytes. , 2007, Progress in experimental tumor research.

[22]  T. L. Drell,et al.  The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockers , 2006, International journal of cancer.

[23]  T. L. Drell,et al.  Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. , 2006, Medical hypotheses.

[24]  P. Sokołowska,et al.  Constitutive activity of beta-adrenergic receptors in C6 glioma cells. , 2005, Pharmacological reports : PR.

[25]  C. Kaltschmidt,et al.  Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs , 2004, International journal of cancer.

[26]  Edna Maria Vissoci Reiche,et al.  Stress, depression, the immune system, and cancer. , 2004, The Lancet. Oncology.

[27]  Kerstin Lang,et al.  Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. , 2004, The Lancet. Oncology.

[28]  T. L. Drell,et al.  Effects of Neurotransmitters on the Chemokinesis and Chemotaxis of MDA-MB-468 Human Breast Carcinoma Cells , 2003, Breast Cancer Research and Treatment.

[29]  K. Zänker,et al.  Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. , 2003, Immunology letters.

[30]  I. N. Reid,et al.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma , 2002, The Prostate.

[31]  T. L. Drell,et al.  Neurotransmitters are regulators for the migration of tumor cells and leukocytes , 2002, Cancer Immunology, Immunotherapy.

[32]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[33]  K. Zänker,et al.  Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. , 2001, Cancer research.

[34]  Liotta La.  An attractive force in metastasis. , 2001 .

[35]  G. Shakhar,et al.  In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. , 1998, Journal of immunology.

[36]  D. Felten.  Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. , 1993, Neuropsychobiology.